Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M68.4Revenue $M1.0Net Margin (%)--Altman Z-Score6.2
Enterprise Value $M43.8EPS $-0.1Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score-3.4Pre-tax Margin (%)--Higher ROA y-yN
Price/Book2.910-y EBITDA Growth Rate %-4.1Quick Ratio10.7Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-6.4Current Ratio10.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-65.9Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-77.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M118ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ONCY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ONCYFirst Eagle Investment 2014-09-30 Sold Out $0.563 - $1.66
($1.28)
$ 0.58-55%Sold Out0
ONCYFirst Eagle Investment 2014-06-30 Reduce$1.23 - $1.99
($1.43)
$ 0.58-59%Reduce 55.85%188,600
ONCYFirst Eagle Investment 2013-03-31 Buy $2.99 - $4.67
($3.6)
$ 0.58-84%New holding450,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ONCY is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ONCY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Dillahunty, Mary AnnSenior Officer 2014-11-13Sell1,201$0.61-4.92 view
Hohol, Linda Margaret OwerriDirector 2014-10-20Buy10,000$0.563.57 view
Levy, EdwinDirector 2014-10-03Buy16,000$0.62-6.45 view
Thompson, BradleyDirector, Senior Officer 2014-10-03Buy10,000$0.61-4.92 view
Dinning, James FrancisDirector 2014-10-03Buy10,000$0.61-4.92 view
Dinning, James FrancisDirector 2014-10-02Buy20,000$0.6-3.33 view
Hohol, Linda Margaret OwerriDirector 2014-08-12Buy6,800$1.51-61.59 view
Dinning, James FrancisDirector 2014-07-04Buy15,000$1.45-60 view
Levy, EdwinDirector 2014-01-03Buy5,900$1.72-66.28 view
Dinning, James FrancisDirector 2013-12-13Buy5,000$1.62-64.2 view

Quarterly/Annual Reports about ONCY:

    News about ONCY:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Oncolytics' Reolysin Phase II Lung Cancer Study Enrolled Aug 27 2015
    Oncolytics Biotech® Inc. Collaborators to Present Survival Data from REO 016 Study in Non-Small... Aug 27 2015
    Oncolytics Biotech® Inc. Collaborators to Present Survival Data from REO 016 Study in Non-Small... Aug 27 2015
    Oncolytics Biotech® Inc. Collaborators to Present Survival Data from REO 016 Study in Non-Small... Aug 27 2015
    Oncolytics Biotech® Inc. Announces Completion of Enrollment in Randomized Phase II Non-Small Cell... Aug 26 2015
    Oncolytics Biotech® Inc. Announces Completion of Enrollment in Randomized Phase II Non-Small Cell... Aug 26 2015
    Oncolytics Biotech® Inc. Announces Completion of Enrollment in Randomized Phase II Non-Small Cell... Aug 26 2015
    MEDIA ADVISORY - Oncolytics Biotech® Inc. to Participate in the 35th Annual Canaccord Genuity... Aug 12 2015
    MEDIA ADVISORY - Oncolytics Biotech® Inc. to Participate in the 35th Annual Canaccord Genuity... Aug 12 2015
    MEDIA ADVISORY - Oncolytics Biotech® Inc. to Participate in the 35th Annual Canaccord Genuity... Aug 12 2015
    Oncolytics Biotech® Inc. Announces 2015 Second Quarter Results Aug 06 2015
    Oncolytics reports 2Q loss Aug 06 2015
    Oncolytics reports 2Q loss Aug 06 2015
    Oncolytics Biotech® Inc. Announces 2015 Second Quarter Results Aug 06 2015
    Oncolytics Biotech® Inc. Announces 2015 Second Quarter Results Aug 06 2015
    Oncolytics Biotech® Inc. Collaborators Present Final Data from REO 017 Clinical Study in Pancreatic... Jul 06 2015
    Oncolytics Biotech® Inc. Collaborators Present Final Data from REO 017 Clinical Study in Pancreatic... Jul 06 2015
    Oncolytics Biotech® Inc. Collaborators Present Final Data from REO 017 Clinical Study in Pancreatic... Jul 06 2015
    Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Data at the 9th International... Jun 15 2015
    Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Data at the 9th International... Jun 15 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK